Form D · Biotechnology
ProSorp BioTech, Inc.
Chicago, IL · CIK 0001481430
Offering snapshot reported Jan 21, 2010 · SEC filing
- Reported sold
- $271K Offering amount: $271K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jan 6, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 21, 2010 | Initial | $270,942 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-138035
Source: Form D, filed Jan 21, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guillermo Ameer | Director, Executive |
| Olufunmilayo Arewa | Director, Executive |
| Susan Perkins | Director, Executive |
| Robert Shaw | Promoter |
| Stuart Sprague | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2800 North Orchard Street #601
Chicago, IL, 60657
Chicago, IL, 60657